Physician and Patient Perception of Adjustable Maintenance Dosing of Symbicort Turbuhaler.

Trial Profile

Physician and Patient Perception of Adjustable Maintenance Dosing of Symbicort Turbuhaler.

Completed
Phase of Trial: Phase III

Latest Information Update: 27 Mar 2013

At a glance

  • Drugs Budesonide/formoterol (Primary)
  • Indications Asthma
  • Focus Therapeutic Use
  • Acronyms REALITY
  • Sponsors AstraZeneca
  • Most Recent Events

    • 27 Mar 2013 Treatment table added.
    • 21 Jan 2011 Actual end date changed from Aug 2006 to Sep 2006 as reported by ClinicalTrials.gov record.
    • 30 Dec 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top